Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vi Polysaccharide Typhoid Vaccine

Approval Number

国药准字S10960015

Company北京生物制品研究所有限责任公司

Registration Date

July 19, 2022

Previous Approval Numbers

国药准字S10960015

Drug Information

Generic Name

伤寒Vi多糖疫苗

Dosage Form

注射剂

Strength

每支5.0ml(10次人用剂量)。每1次人用剂量0.5ml，含伤寒Vi多糖应不低于30μg

Drug Type

生物制品

Registration Date

July 19, 2022

Company Information

Applicant Company

Company Name北京生物制品研究所有限责任公司

Company Address

北京市北京经济技术开发区博兴二路9号院4号楼2层205室

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy